MetLife Investment Advisors »

Ovid Therapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $102k 32k 3.22
2023-09-30 $122k 32k 3.84
2023-06-30 $104k 32k 3.28
2020-09-30 $120k 21k 5.74
2020-06-30 $154k 21k 7.37